See Argentum’s press announcements from the Senior Living Executive Conference in Phoenix.

×
Argentum Logo_RGB2

What’s New?

Loading RSS Feed
Want to receive instant email notifications on new announcements?

Additional Resources


Senior Living Needs Support for Relief & Resources: Help us tell the administration to equitably distribute Provider Relief Fund dollars to senior living providers.
LEARN MORE

About the CDC’s Resources

The Centers for Disease Control and Prevention (CDC) has a dedicated site for COVID-19 and has posted guidance. Here are some direct links you may find useful:

As new information emerges, the CDC continually updates several special topic pages that may be useful:  

Read an updated a situation summary from the Centers for Disease Control and Prevention.

About the FDA’s Resources 

The U.S. Food and Drug Administration’s FAQs continually provides updates on COVID-19 testing, treatments, and fraud warnings. It has uncovered hundreds of fraudulent and unproven products under its Operation Quack Hack campaign. Here are direct links to some important lists:

About Monoclonal Antibody (mAbs) Treatments 

The FDA authorized monoclonal antibody (mAb) treatments for COVID-19 in November 2020 after these treatments were shown to be effective at combatting the disease. Since then, a pilot program was established by the U.S. Department of Health and Human Services (HHS) to increase access to bamlanivimab (Eli Lilly) for COVID-19 in high-risk, eligible individuals residing or working in long-term care facilities, including assisted living. The program utilizes home infusion providers – in partnership with community staff – to identify, assess, coordinate, dispense, and administer monoclonal antibody therapies in these healthcare settings.

We encourage interested senior living communities to have a protocol mapped out ahead of time, as these treatments must be administered ASAP upon confirmation of COVID-19 symptoms. Without a plan in place, treatment will be delayed.

Assisted living communities and skilled nursing facilities experiencing an outbreak of COVID-19 can locate a home infusion provider from the National Home Infusion Association’s HHS Bamlanivimab Pilot Provider List. Infusion providers are available in most states and can be located using this map.

Once a physician’s order has been issued following a positive COVID-19 test, these providers:

  • Secure the mAb treatments
  • Secure consent for the treatment
  • Administer the treatment in the community using the infusion provider’s PPE
  • Monitor the infusion recipient for one hour following treatment, per protocol
  • Address any adverse reactions to the treatment using an emergency kit the infusion provider brings to the community
  • Handle billing and reimbursement following treatment
Learn more about seeking support for monoclonal antibody treatments

Additional Resources:

Argentum COVID-19 Publications

Published May 2021

Pre-Planning Guidance for OSHA Regulatory Compliance

Support for compliance with OSHA workplace safety regulations
Published March 2021

Model Visitation Protocols for Vaccinated Senior Living Communities

Protocols, considerations, and general practices

Resident Engagement and Socialization During COVID-19

Guidance in preventing resident social isolation
Published November 2020

Argentum Guidance for Infection Prevention and Control

IPC guidance designed for assisted living communities
Updated November 2020

COVID-19 Community Access and Infection Control

FAQs, Sample Screening Checklist
Published October 2020

Essential Caregiver Toolkit

Regulatory model and guidance
Published June 2020

Managing COVID-19 Restrictions

White paper
Published May 2020

The Need for a "Smart" Testing Strategy

White paper

Argentum, its executive staff and consultants, have attempted to provide the best possible information as a service to the association’s membership in a situation that is very quickly evolving and about which so much is unknown. Therefore, Argentum can provide no assurances nor even make any representations about the reliability or accuracy of this information. Each senior living company and each community must make decisions that each regards as in the best interests of the health and safety of the residents. Argentum specifically disclaims responsibility or liability for the information it is providing from any legal, regulatory, medical, or compliance point of view.

Stay Connected

Get updates on the latest news impacting senior living through our Argentum Daily newsletter.

×

Login.

Forgot Password
Create an Account